Moderna reins in 2024 sales forecast, expects very low EU vaccine revenue
MODERNA slashed its 2024 forecast for sales of its Covid-19 and respiratory syncytial virus vaccines by up to 25 per ...
MODERNA slashed its 2024 forecast for sales of its Covid-19 and respiratory syncytial virus vaccines by up to 25 per ...
MODERNA on Thursday (Aug 1) cut its 2024 sales forecast for Covid-19 and respiratory syncytial virus vaccines by up to ...
The US government has awarded US$176 million to Moderna to advance development of its bird flu vaccine, the company said ...
Moderna reported a narrower first-quarter loss than Wall Street had expected, as the biotech giant’s cost-cutting helped offset a steep ...
MODERNA reported fourth-quarter revenue that beat analysts’ expectations by gaining Covid vaccine market share on its rival, Pfizer. The company ...
Moderna on Friday announced in a press release it was suing Pfizer and BioNTech for patent infringement over intellectual property ...
Entrepreneurs 40under40 is a premier platform dedicated to recognizing and empowering young entrepreneurs under the age of 40.
© 2024 Entrepreneurs 40under40. All Rights Reserved